| Primary |
| Antiviral Prophylaxis |
50.0% |
| Immunisation |
50.0% |
|
| Pyrexia |
75.0% |
| Urticaria |
25.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
28.1% |
| Product Used For Unknown Indication |
16.9% |
| Lung Squamous Cell Carcinoma Stage Iii |
6.7% |
| Prophylaxis |
6.7% |
| Epilepsy |
4.5% |
| Immunisation |
4.5% |
| Antiviral Prophylaxis |
3.4% |
| Depression |
3.4% |
| Diabetes Mellitus |
3.4% |
| Atrial Fibrillation |
2.2% |
| Hypertension |
2.2% |
| Infection |
2.2% |
| Influenza |
2.2% |
| Influenza Immunisation |
2.2% |
| Pain |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Smoking Cessation Therapy |
2.2% |
| Urinary Tract Infection |
2.2% |
| Anxiety |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Traumatic Lung Injury |
13.6% |
| Drug Toxicity |
9.1% |
| International Normalised Ratio Increased |
9.1% |
| Toxic Skin Eruption |
9.1% |
| Chest Discomfort |
4.5% |
| Cleft Palate |
4.5% |
| Dysarthria |
4.5% |
| Osteoporosis |
4.5% |
| Paraesthesia |
4.5% |
| Pneumonia |
4.5% |
| Pruritus |
4.5% |
| Rash Maculo-papular |
4.5% |
| Rhabdomyolysis |
4.5% |
| Rhinitis |
4.5% |
| Syncope |
4.5% |
| Tongue Ulceration |
4.5% |
| Vaccination Site Reaction |
4.5% |
|
| Concomitant |
| Prostate Cancer Metastatic |
10.8% |
| Mental Disorder |
9.6% |
| Prophylaxis |
8.7% |
| Asthma |
7.2% |
| Dyspepsia |
6.3% |
| Drug Use For Unknown Indication |
6.0% |
| Hypertension |
5.4% |
| Product Used For Unknown Indication |
5.4% |
| Multiple Myeloma |
5.1% |
| Anxiety |
4.8% |
| Somatoform Disorder |
4.8% |
| Chronic Obstructive Pulmonary Disease |
3.6% |
| Pain In Jaw |
3.3% |
| Blood Cholesterol Increased |
3.0% |
| Bone Neoplasm Malignant |
3.0% |
| Multiple Sclerosis |
3.0% |
| Pain |
3.0% |
| Herpes Zoster |
2.4% |
| Menopause |
2.4% |
| Breast Cancer Metastatic |
2.1% |
|
| Weight Decreased |
21.7% |
| Withdrawal Of Life Support |
13.0% |
| Vision Blurred |
7.2% |
| Restlessness |
5.8% |
| Suicidal Ideation |
5.8% |
| Vomiting |
4.3% |
| Yellow Skin |
4.3% |
| Akathisia |
2.9% |
| Aortic Valve Sclerosis |
2.9% |
| Drug Ineffective |
2.9% |
| Dyspepsia |
2.9% |
| Hypercholesterolaemia |
2.9% |
| Lung Neoplasm |
2.9% |
| Neoplasm Progression |
2.9% |
| Neuralgia |
2.9% |
| Osteonecrosis |
2.9% |
| Renal Artery Stenosis |
2.9% |
| Sepsis |
2.9% |
| Syncope |
2.9% |
| Upper Respiratory Tract Infection |
2.9% |
|
